Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Toyota

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Anticancer Research|February 16, 2006
Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Hiroko Toyota, Seiji Kondo, Satoru Kyo, et al.
Cellular & Molecular Biology Letters|December 6, 2011
Thy28 partially prevents apoptosis induction following engagement of membrane immunoglobulin in WEHI-231 B lymphoma cellsHiroko Toyota, Xiao-Zhou Jiang, Hideki Asakura, et al.
Oncology Reports|September 30, 2009
Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cellsTakenori Noutomi, Mizue Itoh, Hiroko Toyota, et al.
Immunology Letters|February 20, 2002
Requirement of c-Jun N terminal kinase and P38 mitogen-activated protein kinase for anti-IgM-induced reduction in mitochondrial membrane potential in CH31 B lymphoma cellsEiko Takada, Hiroko Toyota, Masae Furuhata, et al.
Cancer Letters|December 20, 2002
Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type BaxHiroko Toyota, Noriko Yanase, Takayuki Yoshimoto, et al.
Oncology Reports|November 15, 2014
Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivoHiroko Toyota, Noriko Yanase, Takayuki Yoshimoto, et al.
Cell Reports|August 27, 2024
Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class IIEi Wakamatsu, Hiroaki Machiyama, Hiroko Toyota, et al.
Tissue & Cell|October 29, 2003
Modulation of mThy28 nuclear protein expression during thymocyte developmentXiaozhou Jiang, Hiroko Toyota, Eiko Takada, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 18, 2006
Apoptosis induced by chemotherapeutic agents involves c-Jun N-terminal kinase activation in sarcoma cell linesTakaaki Koyama, Takashi Mikami, Takashi Koyama, et al.
Melanoma Research|September 27, 2003
Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteinsHirofumi Shibuya, Yukihiko Kato, Masuyoshi Saito, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Anticancer Research|February 16, 2006
Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Hiroko Toyota, Seiji Kondo, Satoru Kyo, et al.
Cellular & Molecular Biology Letters|December 6, 2011
Thy28 partially prevents apoptosis induction following engagement of membrane immunoglobulin in WEHI-231 B lymphoma cellsHiroko Toyota, Xiao-Zhou Jiang, Hideki Asakura, et al.
Oncology Reports|September 30, 2009
Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cellsTakenori Noutomi, Mizue Itoh, Hiroko Toyota, et al.
Immunology Letters|February 20, 2002
Requirement of c-Jun N terminal kinase and P38 mitogen-activated protein kinase for anti-IgM-induced reduction in mitochondrial membrane potential in CH31 B lymphoma cellsEiko Takada, Hiroko Toyota, Masae Furuhata, et al.
Cancer Letters|December 20, 2002
Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type BaxHiroko Toyota, Noriko Yanase, Takayuki Yoshimoto, et al.
Oncology Reports|November 15, 2014
Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivoHiroko Toyota, Noriko Yanase, Takayuki Yoshimoto, et al.
Cell Reports|August 27, 2024
Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class IIEi Wakamatsu, Hiroaki Machiyama, Hiroko Toyota, et al.
Tissue & Cell|October 29, 2003
Modulation of mThy28 nuclear protein expression during thymocyte developmentXiaozhou Jiang, Hiroko Toyota, Eiko Takada, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 18, 2006
Apoptosis induced by chemotherapeutic agents involves c-Jun N-terminal kinase activation in sarcoma cell linesTakaaki Koyama, Takashi Mikami, Takashi Koyama, et al.
Melanoma Research|September 27, 2003
Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteinsHirofumi Shibuya, Yukihiko Kato, Masuyoshi Saito, et al.
Pageof 3